The ongoing opioid crisis has affected countless lives, leaving individuals and families grappling with addiction and its devastating consequences. Amid this turmoil, researchers funded by the National Institutes of Health (NIH) have been diligently working on a novel solution that could change the
Resistant hypertension affects more than half of patients suffering from high blood pressure, presenting a significant challenge for healthcare providers. This condition often remains uncontrolled by multiple medications, typically linked to elevated levels of aldosterone, a hormone regulating
The recent halt of life-saving drug trials due to an unanticipated funding freeze by the U.S. government has created significant uncertainty and disruption in the fight against malaria, a disease that remains a major global health threat. This decision, stemming from an initiative by the Trump
The oversight practices of the Food and Drug Administration (FDA) regarding food additives and substances have come under scrutiny. This article explores the FDA's regulation of food safety, the autonomy granted to food companies, and the health risks associated with certain ingredients,
Ivan Kairatov is a Biopharma expert with a wealth of knowledge in tech and innovation within the industry, bolstered by extensive experience in research and development. Today's interview will delve into the impact of recent administrative changes on VA hospitals, specifically examining the role of
On March 3, 2025, Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focusing on targeting the CLEVER-1 receptor to reprogram myeloid cells for anti-tumor immunity in both hematological and solid tumors, announced a significant milestone. Their lead therapeutic candidate,
